BioSpace News Archive

Pharm Country

Physicians’ Education Resource® to Host 15th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

Physicians’ Education Resource® (PER®), a leading resource for continuing medical education (CME), will host its 15th annual International Symposium on Melanoma and Other Cutaneous Malignancies® Saturday, Feb. 9, at the InterContinental New York Times Square in New York City.

January 17, 2019
·
3 min read
Business

Remedi SeniorCare Hires Esteemed Long-Term Care Pharmacy Executives in Houston, Texas

Jeffrey M. Stamps, R.Ph., President and CEO of Remedi SeniorCare, announces new members of the leadership team for a new pharmacy in Houston, Texas.

January 17, 2019
·
2 min read
BioCapital

For Men Suffering From Chronic Testicular Pain, Specialized “Cord Stripping” Surgery Finally Delivers Relief

The problem many men find is that not many physicians understand the origins of chronic testicular pain (CTP) or know how to accurately diagnose and treat this chronic condition. Fortunately, there is relief for men with this condition.

January 17, 2019
·
4 min read
Pharm Country

Brain’s Cerebellum Found to Influence Addictive and Social Behavior

In a study published online today in the journal Science, researchers at Albert Einstein College of Medicine, part of Montefiore, prove for the first time that the brain’s cerebellum—long thought to be mainly involved in coordinating movement—helps control the brain’s reward circuitry.

January 17, 2019
·
8 min read
Synairgen announces positive progress on LOXL2 programme by Pharmaxis

Synairgen (LSE: SNG), the respiratory drug discovery and development company, is pleased to note that Pharmaxis has reported receipt of all data for the LOXL2 inhibitor candidates in three-month toxicity studies.

January 17, 2019
·
3 min read
BioMidwest

Millendo Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

The option awards have an exercise price of $8.80 per share, the closing price per share of the Company’s common stock on January 15, 2019.

January 17, 2019
·
3 min read
Drug Development

Taiho Oncology and Servier Present Data on LONSURF® (trifluridine/tipiracil) at ASCO 2019 Gastrointestinal Cancers Symposium (ASCO GI)

Taiho Oncology, Inc. and Servier announced that the safety and efficacy in patients with gastrectomy from the global Phase 3 TAGS trial evaluating LONSURF® in patients with previously treated metastatic gastric cancer (mGC) are consistent with the overall study results published in The Lancet Oncology.

January 17, 2019
·
14 min read
Business

BioIQ White Paper Provides Insights for Employers on Tackling High Cost of Flu

Paper provides retail and consumer-based strategies to help drive program engagement and ROI

January 17, 2019
·
3 min read
Business

Georgia Bio Bolsters Policy Resources Naming Joseph Santoro New VP of Business Development and External Affairs

This newly created role will provide expanded leadership in developing and implementing sound public policy strategies for Georgia Bio members and strengthen the voice of life sciences in the state.

January 17, 2019
·
2 min read
Deals

Medicine Man Technologies, Inc. announces launch of direct operator division of licensed cannabis operations

Today Medicine Man Technologies (OTCQX: MDCL), a leading consulting, intellectual property licensing and products company in the cannabis industry, has announced a binding agreement that is expected to lead to the near-term acquisition of the Colorado licensee, Medicine Man Denver (

January 17, 2019
·
5 min read